Nearly 800,000 Afrin nasal sprays recalled over safety risk for children

Safety officials believe the bottles may pose a risk if swallowed by children, as they lack required safety features and warning labels.

More than 780,000 travel-size nasal spray bottles are being recalled because their packaging does not meet federal child safety requirements, Consumer Product Safety officials said.

The recall involves about 786,100 bottles of Afrin Original Nasal Spray 6 mL distributed by Bayer HealthCare LLC.

According to the recall notice issued April 30, the 6 mL bottles contain an imidazoline, a type of medication that must be sold in child-resistant packaging under the Poison Prevention

This post was originally published on this site

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top